Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial-Reference-Cited by-同舟云学术

Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial

Published:2018-06-20 Issue:7 Volume:32 Page:1657-1669
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Suttorp Meinolf,Schulze Philipp,Glauche Ingmar^ORCID,Göhring Gudrun,von Neuhoff Nils,Metzler Markus,Sedlacek Petr,de Bont Eveline S. J. M.,Balduzzi Adriana,Lausen Birgitte,Aleinikova Olga,Sufliarska Sabina,Henze Günter,Strauss Gabriele,Eggert Angelika,Kremens Bernhard,Groll Andreas H.,Berthold Frank,Klein Christoph^ORCID,Groß-Wieltsch Ute,Sykora Karl Walter,Borkhardt Arndt^ORCID,Kulozik Andreas E.^ORCID,Schrappe Martin,Nowasz Christina,Krumbholz Manuela,Tauer Josephine T.,Claviez Alexander,Harbott Jochen,Kreipe Hans H.,Schlegelberger Brigitte,Thiede Christian

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-018-0179-9.pdf

Reference64 articles.

1. Cortes J, Talpaz M, O’Brien S, Giles F, Beth RM, Shan J, et al. Effects of age on prognosis with imatinib mesylate therapy for patients with Philadelphia chromosome-positive chronic myelogenous leukemia. Cancer. 2003;98:1105–13.

2. Cwynarski K, Roberts IA, Iacobelli S, van BA, Brand R, Devergie A, et al. Stem cell transplantation for chronic myeloid leukemia in children. Blood. 2003;102:1224–31.

3. Suttorp M, Claviez A, Bader P, Peters C, Gadner H, Ebell W, et al. Allogeneic stem cell transplantation for pediatric and adolescent patients with CML: results from the prospective trial CML-paed I. Klin Padiatr. 2009;221:351–7.

4. Chaudhury S, Sparapani R, Hu ZH, Nishihori T, bdel-Azim H, Malone A, et al. Outcomes of allogeneic hematopoietic cell transplantation in children and young adults with chronic myeloid leukemia: a CIBMTR cohort analysis. Biol Blood Marrow Transplant. 2016;22:1056–64.

5. Champagne MA, Capdeville R, Krailo M, Qu W, Peng B, Rosamilia M, et al. Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children’s Oncology Group phase 1 study. Blood. 2004;104:2655–60.

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Tyrosine Kinase Inhibitors (TKIs) on Growth in Children and Adolescents with Chronic Myeloid Leukemia: A Systematic Review;Current Pharmaceutical Design;2024-09

2. Critical review of clinical data and expert-based recommendations for the use of bosutinib in the treatment of chronic myeloid leukemia;Frontiers in Oncology;2024-08-26

3. Pediatric Myelofibrosis: A Rare Entity Posing a Diagnostic Challenge;Iranian Journal of Pediatric Hematology & Oncology;2024-06-30

4. Screening and interventional strategies for the late effects and toxicities of hematological malignancy treatments in pediatric survivors;Expert Review of Hematology;2024-06-25

5. Haematopoietic stem cell transplantation after reduced intensity conditioning in children and adolescents with chronic myeloid leukaemia: A prospective multicentre trial of the I‐BFM Study Group;British Journal of Haematology;2024-05-27